Clinical Study

STK11 rs2075604 Polymorphism Is Associated with Metformin Efficacy in Chinese Type 2 Diabetes Mellitus

Table 4

Association between STK11 rs2075604 genetic polymorphism and metformin efficacy in T2DM patients (adjusted for age, gender, and BMI).

rs2075604 (G>T)Non-response ()Response ()OR (95% CI)

Genotypes
 GG18 (56.25%)18 (29.03%)1.0 (reference)
 GT11 (34.37%)34 (54.84%)3.091 (1.204–7.936)0.019
 TT3 (9.38%)10 (16.13%)1.826 (0.886–3.762)0.103
Alleles
 G47 (73.44%)70 (56.45%)1.0 (reference)
 T17 (26.56%)54 (43.55%)2.133 (1.104–4.121)0.024
GG versus GT/TT (dominant model)3.143 (1.293–7.638)0.011
GG/GT versus TT (recessive model)1.721 (0.430–6.888)0.443

Data was analyzed by the logistic regression by adjusting for sex, age, and BMI. OR: odds ratio; CI: confidence interval. The numbers in bold indicated statistically significant values.